Although the exact contribution of ICOS in glioma progression is not well understood, the immunosuppressive effect of ICOS may be attributed to increased activation and occurrence of Tregs (29, 46), and downregulation of these cells enhanced the impact of immunotherapy (50). The gene discussed is ICOS; the disease is glioma.